These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 16610945)

  • 1. The challenge of integrating disparate high-content data: epidemiological, clinical and laboratory data collected during an in-hospital study of chronic fatigue syndrome.
    Vernon SD; Reeves WC
    Pharmacogenomics; 2006 Apr; 7(3):345-54. PubMed ID: 16610945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoid receptor polymorphisms and haplotypes associated with chronic fatigue syndrome.
    Rajeevan MS; Smith AK; Dimulescu I; Unger ER; Vernon SD; Heim C; Reeves WC
    Genes Brain Behav; 2007 Mar; 6(2):167-76. PubMed ID: 16740143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic fatigue syndrome and high allostatic load: results from a population-based case-control study in Georgia.
    Maloney EM; Boneva R; Nater UM; Reeves WC
    Psychosom Med; 2009 Jun; 71(5):549-56. PubMed ID: 19414615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression profile exploration of a large dataset on chronic fatigue syndrome.
    Fang H; Xie Q; Boneva R; Fostel J; Perkins R; Tong W
    Pharmacogenomics; 2006 Apr; 7(3):429-40. PubMed ID: 16610953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional status in patients with chronic fatigue syndrome, other fatiguing illnesses, and healthy individuals.
    Buchwald D; Pearlman T; Umali J; Schmaling K; Katon W
    Am J Med; 1996 Oct; 101(4):364-70. PubMed ID: 8873506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coping styles in people with chronic fatigue syndrome identified from the general population of Wichita, KS.
    Nater UM; Wagner D; Solomon L; Jones JF; Unger ER; Papanicolaou DA; Reeves WC; Heim C
    J Psychosom Res; 2006 Jun; 60(6):567-73. PubMed ID: 16731231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early adverse experience and risk for chronic fatigue syndrome: results from a population-based study.
    Heim C; Wagner D; Maloney E; Papanicolaou DA; Solomon L; Jones JF; Unger ER; Reeves WC
    Arch Gen Psychiatry; 2006 Nov; 63(11):1258-66. PubMed ID: 17088506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic fatigue syndrome and high allostatic load.
    Maloney EM; Gurbaxani BM; Jones JF; de Souza Coelho L; Pennachin C; Goertzel BN
    Pharmacogenomics; 2006 Apr; 7(3):467-73. PubMed ID: 16610956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between neuroendocrine responses to the Insulin Tolerance Test and patient characteristics in chronic fatigue syndrome.
    Gaab J; Engert V; Heitz V; Schad T; Schürmeyer TH; Ehlert U
    J Psychosom Res; 2004 Apr; 56(4):419-24. PubMed ID: 15094026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allostatic load is associated with symptoms in chronic fatigue syndrome patients.
    Goertzel BN; Pennachin C; de Souza Coelho L; Maloney EM; Jones JF; Gurbaxani B
    Pharmacogenomics; 2006 Apr; 7(3):485-94. PubMed ID: 16610958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of brief exercise cessation on pain, fatigue, and mood symptom development in healthy, fit individuals.
    Glass JM; Lyden AK; Petzke F; Stein P; Whalen G; Ambrose K; Chrousos G; Clauw DJ
    J Psychosom Res; 2004 Oct; 57(4):391-8. PubMed ID: 15518675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of peripheral inflammatory markers with chronic fatigue in a population-based sample.
    Raison CL; Lin JM; Reeves WC
    Brain Behav Immun; 2009 Mar; 23(3):327-37. PubMed ID: 19111923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges for molecular profiling of chronic fatigue syndrome.
    Vernon SD; Whistler T; Aslakson E; Rajeevan M; Reeves WC
    Pharmacogenomics; 2006 Mar; 7(2):211-8. PubMed ID: 16515400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychiatric comorbidity in persons with chronic fatigue syndrome identified from the Georgia population.
    Nater UM; Lin JM; Maloney EM; Jones JF; Tian H; Boneva RS; Raison CL; Reeves WC; Heim C
    Psychosom Med; 2009 Jun; 71(5):557-65. PubMed ID: 19414619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linear data mining the Wichita clinical matrix suggests sleep and allostatic load involvement in chronic fatigue syndrome.
    Gurbaxani BM; Jones JF; Goertzel BN; Maloney EM
    Pharmacogenomics; 2006 Apr; 7(3):455-65. PubMed ID: 16610955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 24-hour pituitary and adrenal hormone profiles in chronic fatigue syndrome.
    Di Giorgio A; Hudson M; Jerjes W; Cleare AJ
    Psychosom Med; 2005; 67(3):433-40. PubMed ID: 15911907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and incidence of chronic fatigue syndrome in Wichita, Kansas.
    Reyes M; Nisenbaum R; Hoaglin DC; Unger ER; Emmons C; Randall B; Stewart JA; Abbey S; Jones JF; Gantz N; Minden S; Reeves WC
    Arch Intern Med; 2003 Jul; 163(13):1530-6. PubMed ID: 12860574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor analysis of symptoms among subjects with unexplained chronic fatigue: what can we learn about chronic fatigue syndrome?
    Nisenbaum R; Reyes M; Unger ER; Reeves WC
    J Psychosom Res; 2004 Feb; 56(2):171-8. PubMed ID: 15016574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploration of statistical dependence between illness parameters using the entropy correlation coefficient.
    Craddock RC; Taylor R; Broderick G; Whistler T; Klimas N; Unger ER
    Pharmacogenomics; 2006 Apr; 7(3):421-8. PubMed ID: 16610952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A population-based study of the clinical course of chronic fatigue syndrome.
    Nisenbaum R; Jones JF; Unger ER; Reyes M; Reeves WC
    Health Qual Life Outcomes; 2003 Oct; 1():49. PubMed ID: 14613572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.